Skip to main content

and
  1. Article

    Open Access

    Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

    To improve breast cancer risk stratification to enable more targeted early detection/prevention strategies that will better balance risks and benefits of population screening programmes.

    D. Gareth R. Evans, Elaine F. Harkness in Breast Cancer Research and Treatment (2019)

  2. Article

    Open Access

    PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

    Poly(ADP-ribose) polymerase inhibitors (PARPi) have changed the management of high-grade serous ovarian cancer (HGSOC). The rationale for the development of PARPi was based on the concept of synthetic lethalit...

    Robert D. Morgan, Andrew R. Clamp in Cancer Chemotherapy and Pharmacology (2018)

  3. No Access

    Article

    Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral

    The aim of this study was to establish if risk-reducing surgery (RRS) increases survival among BRCA1/2 carriers without breast/ovarian cancer at the time of family referral. Female BRCA1/2 carriers were identifie...

    Sarah L. Ingham, Matthew Sperrin, Andrew Baildam in Breast Cancer Research and Treatment (2013)

  4. No Access

    Article

    Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer

    BRCA1/2 mutation carriers with breast cancer are at high risk of contralateral disease. Such women often elect to have contralateral risk-reducing mastectomy (CRRM) to reduce the likelihood of re...

    D. Gareth R. Evans, Sarah L. Ingham, Andrew Baildam in Breast Cancer Research and Treatment (2013)

  5. No Access

    Article

    High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?

    Miriam J. Smith, Franchesca L. Gifford in Breast Cancer Research and Treatment (2012)

  6. No Access

    Article

    Mechanisms of Disease: prediction and prevention of breast cancer—cellular and molecular interactions

    Breast cancer is a multifactorial condition, and changes in cellular biology are affected by a large number of variables known to affect an individual's susceptibility to this malignancy. Current risk predicti...

    Anthony Howell, Andrew H Sims, Kai Ren Ong in Nature Clinical Practice Oncology (2005)

  7. No Access

    Article

    Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

    The molecular basis for most non-HNPCC familial colorectal cancer cases is unknown, but there is increasing evidence that common genetic variants may play a role. We investigated the contribution of polymorphi...

    Timothy R Porter, Frances M Richards, Richard S Houlston, D Gareth R Evans in Oncogene (2002)

  8. No Access

    Article

    Relative frequency and morphology of cancers in carriers of germline TP53 mutations

    The spectrum and frequency of cancers associated with germline TP53 mutations are uncertain. To address this issue a cohort of individuals from 28 families with Li-Fraumeni syndrome, segregating germline TP53 ...

    Jillian M Birch, Robert D Alston, Richard JQ McNally, D Gareth R Evans in Oncogene (2001)